Yaoguang Huang

Discovery of novel β-carboline derivatives as selective AChE inhibitors with GSK-3β inhibitory property for the treatment of Alzheimer's disease

Wenwu Liu, Xin Liu, Wenjie Liu et al. · European Journal of Medicinal Chemistry · 2021 · 45 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

An inhibitor with GSK3β and DYRK1A dual inhibitory properties reduces Tau hyperphosphorylation and ameliorates disease in models of Alzheimer's disease

Xin Liu, Lingyun Lai, Jiang-xia Chen et al. · Neuropharmacology · 2023 · 28 citations

Life Sciences, Molecular Biology, Neuroscience +14

Discovery of novel harmine derivatives as GSK‐3β/DYRK1A dual inhibitors for Alzheimer's disease treatment

Jingsong Qiu, Xiangling Feng, Huanhua Chen et al. · Archiv der Pharmazie · 2023 · 19 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Discovery of novel tacrine derivatives as potent antiproliferative agents with CDKs inhibitory property

Wenwu Liu, Limeng Wu, Deping Li et al. · Bioorganic Chemistry · 2022 · 16 citations

Medicine, Medicinal Chemistry, Pharmacology +9

Discovery of novel benzofuro[3,2-b]quinoline derivatives as dual CDK2/Topo I inhibitors

Yaoguang Huang, Wenwu Liu, Shuoqi Huang et al. · Bioorganic Chemistry · 2022 · 14 citations

Pharmacy, Chemistry, Medicinal Chemistry +12